Rani Therapeutics Holdings Class ARANI

13F holders, Q3 2025 (September 30)
38holders −1
6new positions
7sold out
2famous investors
$0.50avg. 13F price*

At the end of Q3 2025, 38 institutions reported holding Rani Therapeutics Holdings Class A (RANI) in their 13F filings, down 1 from Q2 2025. 6 opened new positions and 7 sold out. The largest holders were Vanguard Group Inc. ($442K), Nan Fung Group Holdings Ltd ($247K) and Citadel Advisors ($226K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).

Company
Rani Therapeutics Holdings Class A
CUSIP
753018100
Latest filing quarter
Q2 2026

History

Number of 13F holders

020406080 Q1 2024: 37Q1 2024Q2 2024: 34Q2 2024Q3 2024: 31Q3 2024Q4 2024: 42Q4 2024Q1 2025: 38Q1 2025Q2 2025: 39Q2 2025Q3 2025: 38Q3 2025Q4 2025: 64Q4 2025Q1 2026: 74Q1 2026Q2 2026: 68Q2 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions6$98K
Exits7$1.7M

All 13F filers, Q2 2025 → Q3 2025: 853,600 shares bought and 3,278,193 shares sold, net −2,424,593 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 38 holders

Vanguard Group Inc. 0.00% Add +10.6% 884,609 $442K
Nan Fung Group Holdings Ltd 0.41% No change 493,584 $247K
Citadel Advisors 0.00% Add +229.5% 452,542 $226K
United Services Automobile Association 0.01% No change 302,743 $151K
Geode Capital Management, LLC 0.00% Add +55.8% 296,910 $148K
Kestra Private Wealth Services, LLC 0.00% Add +44.8% 226,142 $113K
Takeda Pharmaceutical Co. Ltd. 0.62% No change 203,190 $102K
CWA Asset Management Group, LLC 0.00% Add +80.0% 150,000 $75K
BlackRock, Inc. 0.00% Add +1.3% 120,232 $60K
HRT Financial LP 0.00% New 113,206 $56K
Northern Trust Corp. 0.00% Reduce -5.7% 97,005 $48K
UBS Group AG 0.00% Add +11.4% 69,123 $35K
Lasry Marc 0.21% No change 62,887 $31K
State Street Corp. 0.00% No change 62,442 $31K
King Luther Capital Management Corp. 0.00% No change 58,000 $29K
Well Done, LLC 0.00% No change 52,014 $26K
Janney Montgomery Scott LLC 0.00% Reduce -10.9% 49,200 $25K
Motco 0.00% No change 48,129 $24K
Insigneo Advisory Services, LLC 0.00% No change 47,500 $24K
XTX Topco Ltd 0.00% New 44,077 $22K
Brown Advisory Inc. 0.00% No change 32,911 $16K
Prime Capital Investment Advisors, LLC 0.00% No change 27,208 $14K
Renaissance Technologies 0.00% New 24,908 $12K
Lafayette Investments, Inc. 0.00% No change 19,893 $10K
Bank of America Corp. 0.00% Reduce -43.0% 17,752 $9K
ACT Advisors, LLC. 0.00% New 14,806 $7K
SBI Securities Co., Ltd. 0.00% Add +31.3% 12,632 $6K
Choreo, LLC 0.00% No change 11,813 $6K
Cerity Partners LLC 0.00% No change 10,000 $5K
Islay Capital Management, LLC 0.00% No change 9,611 $5K
Morgan Stanley 0.00% Reduce -3.9% 6,750 $3K
Tower Research Capital LLC (TRC) 0.00% Reduce -33.0% 6,224 $3K
Allworth Financial LP 0.00% No change 3,119 $2K
Osaic Holdings, Inc. 0.00% Reduce -85.0% 1,000 $490
EverSource Wealth Advisors, LLC 0.00% New 980 $490
JPMorgan Chase & Co. 0.00% No change 71 $35
Royal Bank of Canada 0.00% Add +25.8% 39 $0
Simplex Trading, LLC 0.00% New 819 $0

"% of holder's portfolio" is RANI's weight in each manager's 13F, not the share of Rani Therapeutics Holdings Class A the manager owns.